Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
The summary for the Midcareer Investigator Award in Patient-Oriented Research (Parent K24) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Midcareer Investigator Award in Patient-Oriented Research (Parent K24): The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates or equivalent who are typically at the Associate Professor level or the equivalent (see Section III. Eligible Individuals) for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.
Federal Grant Title: | Midcareer Investigator Award in Patient-Oriented Research (Parent K24) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Environment Food and Nutrition Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-14-047 |
Type of Funding: | Grant |
CFDA Numbers: | 93.113, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.361, 93.398, 93.837, 93.838, 93.839, 93.846, 93.847, 93.853, 93.855, 93.856, 93.865, 93.866 |
CFDA Descriptions: | Environmental Health; Research Related to Deafness and Communication Disorders; Research and Training in Complementary and Alternative Medicine; National Center on Sleep Disorders Research; Mental Health Research Grants; Alcohol Research Programs; Drug Abuse and Addiction Research Programs; Nursing Research; Cancer Research Manpower; Cardiovascular Diseases Research; Lung Diseases Research; Blood Diseases and Resources Research; Arthritis, Musculoskeletal and Skin Diseases Research; Diabetes, Digestive, and Kidney Diseases Extramural Research; Extramural Research Programs in the Neurosciences and Neurological Disorders; Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research; Child Health and Human Development Extramural Research; Aging Research |
Current Application Deadline: | Jan 7, 2017 |
Original Application Deadline: | Jan 7, 2017 |
Posted Date: | Dec 19, 2013 |
Creation Date: | Dec 19, 2013 |
Archive Date: | Feb 7, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Native American tribal governments (Federally recognized)
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
State governments
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PA-14-047.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed...
- • NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advan...
- • Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clini...
- • Outstanding New Environmental Scientist Award (ONES)
- • Environmental Health Sciences Core Center Grants
- • Leiomyomata Uteri: Basic Science and Translational Research
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)